Company intelligence / Profile preview

Colorado Blood Cancer Institute

Denver, Colorado, United States

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Colorado Blood Cancer Institute is one of the largest and most experienced full-service blood and marrow transplant programs in the U.S., with over 5,800 BMTs completed, including more than 310 BMTs annually and 318 commercial CAR-T cell infusions. It maintains a robust clinical trials portfolio in hematologic malignancies and immune disorders and is accredited by FACT for its leadership in cellular therapies[7][11].

Therapeutic areas: ImmunologyRheumatologyNeurologyRare DiseasesHematologyOncology
Modalities: Cell therapyCAR-T cell therapyBlood and marrow transplantSmall molecule
Industry: Academic Hospital/University/Research

Partnerships

Sarah Cannon Cancer InstitutePresbyterian/St. Luke’s Medical CenterFACT (accreditation)

Beyond the preview

Go deeper on Colorado Blood Cancer Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colorado Blood Cancer Institute.

Explore the full profile